Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-07-10 to 2024-07-11
Current total value of award: $6.27
Description: 4565130505!INSULIN HUMAN INJECTION MODIFIED 100 USP